Showing results (121-130 of 389) with videos related to
Sort By:
Pageof 39
Oncology and Therapy|June 25, 2024
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient SurveyBetty K Hamilton, Paul Williams, John Galvin, et al.Oncology and Therapy|January 16, 2023
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic CancerSandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, et al.Oncology and Therapy|December 24, 2022
Emerging Concepts Impacting Head and Neck Cancer Surgery MorbidityOhad Ronen, K Thomas Robbins, Ashok R Shaha, et al.Oncology and Therapy|July 26, 2021
A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation StatusJenna M Collins, Beth L Nordstrom, Kimmie K McLaurin, et al.Oncology and Therapy|July 7, 2017
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5Steve Schey, Luis Felipe Casado Montero, Chloe Stengel-Tosetti, et al.Oncology and Therapy|July 7, 2017
Second-line Treatments for Advanced Gastric Cancer: A Network Meta-Analysis of Overall Survival Using Parametric Modelling MethodsRebecca C HarveyOncology and Therapy|July 7, 2017
Switching from an LHRH Antagonist to an LHRH Agonist: A Case Report of 10 Finnish Patients with Advanced Prostate CancerHarri VisapääOncology and Therapy|May 13, 2022
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)Jason T Hurwitz, Shannon Vaffis, Amy J Grizzle, et al.Oncology and Therapy|January 13, 2021
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)Kjetil SøreideOncology and Therapy|June 13, 2021
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating MutationsJerry Li, Dana Nickens, Keith Wilner, et al.Pageof 39